Scientists identify new therapeutic approach for combating neurodegenerative diseases

A team led by scientists at the Case Western Reserve University School of Medicine has identified a new therapeutic approach for combating neurodegenerative diseases, offering hope of improved treatments for Alzheimer’s disease, Parkinson’s disease, Vanishing White Matter disease and multiple sclerosis, among others.

SIFI’s AKANTIOR gains EC approval for acanthamoeba keratitis

An ultra-rare, sight-threatening corneal infection, acanthamoeba keratitis causes intense pain and photophobia. Credit: Jo Panuwat D/Shutterstock. Italian ophthalmic company SIFI has received European Commission (EC)

August 27, 2024

How to optimize efficiencies at site-centric clinical trials – Pharmaceutical Technology

The global clinical trials landscape has transformed significantly over the past five years. The Covid-19 pandemic accelerated the rapid adoption of technology through decentralized clinical

September 4, 2024

Pentixapharm Announces Expansion of Supervisory Board with the Appointment of Distinguished Endocrinologist Marcus Quinkler – Biotech Investments

EQS-News: Pentixapharm AG / Key word(s): Personnel Pentixapharm Announces Expansion of Supervisory Board with the Appointment of Distinguished Endocrinologist Marcus Quinkler 01.07.2024 / 13:00 CET/CEST

July 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.